State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.61B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Medtronic
MDT
|
+$1.12B |
| 4 |
American Airlines Group
AAL
|
+$798M |
| 5 |
HCA Healthcare
HCA
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$2.68B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.92B |
| 3 |
Visa
V
|
+$1.24B |
| 4 |
Apple
AAPL
|
+$1.05B |
| 5 |
Wells Fargo
WFC
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.84% |
| 2 | Healthcare | 14.58% |
| 3 | Technology | 13.18% |
| 4 | Industrials | 12.71% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AYR
1676
DELISTED
Aircastle Ltd
AYR
| $25.6M | ﹤0.01% |
1,138,378
-1,008
| -0.1% | -$21.9K |
|
|
GHDX
1677
DELISTED
Genomic Health, Inc.
GHDX
| $25.5M | ﹤0.01% |
836,132
+160,934
| +24% | +$5.12M |
|
|
STBZ
1678
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $25.5M | ﹤0.01% |
1,214,272
+116,101
| +11% | +$2.3M |
|
1679
Bright Horizons
BFAM
$4.04B
| $25.5M | ﹤0.01% |
497,241
+23,513
| +5% | +$1.17M |
|
|
NTUS
1680
DELISTED
Natus Medical Inc
NTUS
| $25.5M | ﹤0.01% |
645,731
+25,212
| +4% | +$930K |
|
1681
Axalta
AXTA
$7.75B
| $25.5M | ﹤0.01% |
922,295
+155,959
| +20% | +$4.21M |
|
|
FPRX
1682
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $25.5M | ﹤0.01% |
1,114,514
+906,383
| +435% | +$22.9M |
|
1683
Interface
TILE
$2.03B
| $25.4M | ﹤0.01% |
1,223,784
+64,392
| +6% | +$1.16M |
|
1684
Protolabs
PRLB
$1.88B
| $25.4M | ﹤0.01% |
363,189
+6,598
| +2% | +$447K |
|
1685
Dorman Products
DORM
$3.88B
| $25.4M | ﹤0.01% |
509,871
+17,435
| +4% | +$821K |
|
|
NAV
1686
DELISTED
Navistar International
NAV
| $25.3M | ﹤0.01% |
858,716
-13,020
| -1% | -$390K |
|
|
ELLI
1687
DELISTED
Ellie Mae Inc
ELLI
| $25.3M | ﹤0.01% |
457,660
+16,271
| +4% | +$792K |
|
|
RFP
1688
DELISTED
Resolute Forest Products Inc.
RFP
| $25.3M | ﹤0.01% |
1,464,414
-42,419
| -3% | -$731K |
|
1689
FirstCash
FCFS
$9.03B
| $25.2M | ﹤0.01% |
541,324
+12,597
| +2% | +$627K |
|
|
MDR
1690
DELISTED
McDermott International
MDR
| $25.2M | ﹤0.01% |
2,185,516
+86,924
| +4% | +$746K |
|
1691
Booz Allen Hamilton
BAH
$8.57B
| $25.2M | ﹤0.01% |
869,369
+68,951
| +9% | +$2.01M |
|
|
HTWR
1692
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $25.2M | ﹤0.01% |
286,638
+3,987
| +1% | +$339K |
|
|
EPE
1693
DELISTED
EP Energy Corporation
EPE
| $25.1M | ﹤0.01% |
2,396,850
+467,976
| +24% | +$4.93M |
|
|
CSOD
1694
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $25.1M | ﹤0.01% |
869,051
+6,991
| +0.8% | +$228K |
|
1695
Vanda Pharmaceuticals
VNDA
$311M
| $25M | ﹤0.01% |
2,685,595
+808,011
| +43% | +$9.13M |
|
|
TPLM
1696
DELISTED
Triangle Petroleum Corporation
TPLM
| $24.9M | ﹤0.01% |
4,949,931
+997,474
| +25% | +$5.07M |
|
|
TYPE
1697
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $24.9M | ﹤0.01% |
762,085
+7,364
| +1% | +$228K |
|
|
VISN
1698
Vistance Networks Inc
VISN
$2.66B
| $24.8M | ﹤0.01% |
869,985
+99,874
| +13% | +$2.78M |
|
1699
Sabesp
SBS
$18.9B
| $24.8M | ﹤0.01% |
23,606,653
+14,282,211
| +153% | +$15.3M |
|
|
PGNX
1700
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $24.7M | ﹤0.01% |
4,127,347
+967,454
| +31% | +$6.09M |
|
Similar funds
State Street's Q1 2015 Portfolio in Review
As of Q1 2015, State Street held 3,759 positions worth $974B, down 2.9% from $1T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
State Street withdrew a net $37.6B in Q1 2015, closing 81 positions and reducing 1,259 holdings. Its most notable exit was Allergan Inc, an estimated $2.68B position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, State Street opened a new position in Qorvo worth $458M.
- State Street's largest Q1 2015 buy was Qorvo: 5,749,623 shares worth $458M.
- State Street added most to Pfizer in Q1 2015, an estimated $1.61B increase.
- State Street's biggest Q1 2015 reduction was Visa, cutting an estimated $1.24B.
- State Street fully exited Allergan Inc in Q1 2015, selling an estimated $2.68B.
- State Street's ten largest holdings make up 15% of its $974B portfolio in Q1 2015.
- State Street opened 60 new positions and closed 81 in Q1 2015.
- State Street's portfolio value fell 2.9% quarter-over-quarter to $974B.
Based on State Street's 13F filing for Q1 2015, filed 15 May 2015.